Firms leaving the uncleared swaps market have nowhere to go

Buy side says cleared or listed products fail to meet their needs

No entry: buy-side firms point out the technological barriers to taking on new listed products

Buy-side firms feel pressure to leave the uncleared derivatives market, but are not finding satisfactory alternatives in the listed space, despite the proliferation of products.

"I was very happy to sit in the over-the-counter world for the whole of my career, and I would continue to carry on sitting in it if it wasn't completely changing. The OTC world was great, because effectively there was what seemed like an infinitely deep, fungible market across whatever product you could be thinking

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to View our subscription options


Want to know what’s included in our free membership? Click here

This address will be used to create your account

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here